Physician profile
Michael Hoffman
NPI 1447219993
$1,051.63
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $34.30 · 2021: $409 · 2022: $117 · 2023: $41.55 · 2024: $14.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $246.42 | 2019-2021 | |
| Heron Therapeutics, INC. | $170.75 | 2021-2022 | |
| Tela Bio, INC. | $149.36 | 2019 | |
| Stryker Corporation | $125.00 | 2019 | |
| Baxter Healthcare | $44.61 | 2021-2022 | |
| Amgen INC. | $39.17 | 2023-2024 | Prolia, Evenity |
| Kci USA, INC. | $39.11 | 2022 | |
| Integra Lifesciences Corporation | $34.71 | 2021 | |
| Intuitive Surgical, INC. | $27.30 | 2022 | |
| Innocoll Pharmaceuticals Limited | $26.88 | 2021 | |
| Covidien Lp | $24.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $22.88 | 2019 | |
| Acera Surgical, INC. | $22.66 | 2019 | |
| Prescient Surgical | $19.83 | 2020 | |
| Genentech USA, INC. | $16.94 | 2023 | Ocrevus |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $14.47 | 2020 | |
| Acell, INC. | $13.51 | 2019 | |
| Merck Sharp & Dohme LLC | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.